November 03, 2025

Metastatic ER-Positive, HER2-Negative Breast Cancer: Novel Treatment Combination Improves Progression-Free Survival

Patients with ER-positive, HER2-negative advanced breast cancer showed significantly improved progression-free survival (PFS) when treated with an oral combination regimen that includes giredestrant, ...

The ASCO Post

October 31, 2025

A Young Hematologist’s Take on ICML 2025

The ASCO Post

October 31, 2025

Addition of Brentuximab Vedotin to Lenalidomide/Rituximab in Relapsed or Refractory DLBCL

The ASCO Post

November 10, 2025

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

The ASCO Post

October 30, 2025

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

The ASCO Post

October 30, 2025

Digital Histopathology and Automated Classification of Pediatric Sarcomas

The ASCO Post

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

February 06, 2026

Baptist Health Miami Cancer Institute Names Bruna Pellini, M.D., Chief of Thoracic Medical Oncology

Baptist Health South Florida

February 06, 2026

Miami Cancer Institute Immunotherapies Summit for Hematologic Malignancies, Seventh Annual

Baptist Health South Florida

February 06, 2026

World Cancer Day: Taking a Proactive Approach to the Most Commonly Diagnosed Cancer

Baptist Health South Florida

February 05, 2026

Chemotherapy-Free Regimen Improves Outcomes in Newly Diagnosed Patients With Ph-Positive ALL

The ASCO Post

February 01, 2026

Dana-Farber Research News 02.01.2026

Dana-Farber

January 31, 2026

Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient

Temple Health

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

Medical Grand Rounds

February 09, 2026

Managing Idiopathic Acute Pancreatitis

Conexiant

ASH 2025

February 05, 2026

Chemotherapy-Free Regimen Improves Outcomes in Newly Diagnosed Patients With Ph-Positive ALL

The ASCO Post

January 08, 2026

Non–Total Body Irradiation Conditioning Regimen for Young Patients With MRD-Negative B-ALL

The ASCO Post

December 15, 2025

Fixed-Duration Doublet Noninferior to Continuous Ibrutinib in CLL

The ASCO Post

2024 ASTRO Annual Meeting

January 28, 2026

Study Finds Standard Chemoradiation Therapy Superior to Deintensification Approaches for HPV-Related Oropharyngeal Cancer

The ASCO Post

October 03, 2024

Duration of Postmastectomy Radiation Therapy in Patients Planning Breast Reconstruction

The ASCO Post

October 02, 2024

Immunotherapy/Chemoradiotherapy for Patients With Limited-Stage Small Cell Lung Cancer

The ASCO Post

Clinical Guidelines

February 06, 2026

World Cancer Day: Taking a Proactive Approach to the Most Commonly Diagnosed Cancer

Baptist Health South Florida

February 05, 2026

Chemotherapy-Free Regimen Improves Outcomes in Newly Diagnosed Patients With Ph-Positive ALL

The ASCO Post

January 31, 2026

Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient

Temple Health

January 29, 2026

Can a BiTE Immunotherapy Improve Survival in Young Patients with High-Risk Kinase-Driven B-ALL Subtypes?

Roswell Park Comprehensive Cancer Center

Commentary & Perspectives

January 31, 2026

Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient

Temple Health

January 30, 2026

Expertise in Rare Tumor Surgery: What Sets Roswell Park Apart

Roswell Park Comprehensive Cancer Center

January 28, 2026

What Should Doctors Know About FDA’s Black Box Change for Hormone Replacement Therapy Drugs?

Keck Medicine of USC

January 23, 2026

Helping Patients Weigh Medical Advice from Friends and Family

Keck Medicine of USC

FDA & Government News

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

February 21, 2024

FDA Approves Biweekly Teclistamab Dosing Regimen for Patients With Multiple Myeloma

The ASCO Post

June 21, 2023

FDA Launches Pilot Program to Help Reduce Risks Associated With Using Laboratory Developed Tests to Identify Cancer Biomarkers

The ASCO Post

Business Management

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

Digital Histopathology and Automated Classification of Pediatric Sarcomas

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

Medical Grand Rounds

ASH 2025

2024 ASTRO Annual Meeting

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management